MPZL2 anticorps (N-Term)
Aperçu rapide pour MPZL2 anticorps (N-Term) (ABIN634708)
Antigène
Voir toutes MPZL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- MPZL2 antibody was raised against the N terminal of MPZL2
-
Purification
- Affinity purified
-
Immunogène
- MPZL2 antibody was raised using the N terminal of MPZL2 corresponding to a region with amino acids LEAVNGTDARLKCTFSSFAPVGDALTVTWNFRPLDGGPEQFVFYYHIDPF
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MPZL2 Blocking Peptide, (ABIN940267), is also available for use as a blocking control in assays to test for specificity of this MPZL2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MPZL2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
-
Autre désignation
- MPZL2
-
Sujet
- Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis.
-
Poids moléculaire
- 22 kDa (MW of target protein)
Antigène
-